109 related articles for article (PubMed ID: 2036219)
1. Reproducibility of histopathological evaluation in epithelial ovarian carcinoma. Clinical implications.
Lund B; Thomsen HK; Olsen J
APMIS; 1991 Apr; 99(4):353-8. PubMed ID: 2036219
[TBL] [Abstract][Full Text] [Related]
2. Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.
Gilks CB; Ionescu DN; Kalloger SE; Köbel M; Irving J; Clarke B; Santos J; Le N; Moravan V; Swenerton K;
Hum Pathol; 2008 Aug; 39(8):1239-51. PubMed ID: 18602670
[TBL] [Abstract][Full Text] [Related]
3. Observer variation in histologic classification of malignant and borderline ovarian tumors.
Stalsberg H; Abeler V; Blom GP; Bostad L; Skarland E; Westgaard G
Hum Pathol; 1988 Sep; 19(9):1030-5. PubMed ID: 3417288
[TBL] [Abstract][Full Text] [Related]
4. Observer disagreement in histological classification of ovarian tumors in Japan.
Sakamoto A; Sasaki H; Furusato M; Suzuki M; Hirai Y; Tsugane S; Fukushima M; Terashima Y
Gynecol Oncol; 1994 Jul; 54(1):54-8. PubMed ID: 8020839
[TBL] [Abstract][Full Text] [Related]
5. Interobserver variability in the interpretation of epithelial ovarian cancer.
Hernandez E; Bhagavan BS; Parmley TH; Rosenshein NB
Gynecol Oncol; 1984 Jan; 17(1):117-23. PubMed ID: 6693048
[TBL] [Abstract][Full Text] [Related]
6. Inter-pathologist and pathology report agreement for ovarian tumor characteristics in the Nurses' Health Studies.
Barnard ME; Pyden A; Rice MS; Linares M; Tworoger SS; Howitt BE; Meserve EE; Hecht JL
Gynecol Oncol; 2018 Sep; 150(3):521-526. PubMed ID: 30001835
[TBL] [Abstract][Full Text] [Related]
7. Pathological classification and grading of primary ovarian carcinoma: experience of the ARTAC ovarian study group.
Vacher-Lavenu MC; Le Tourneau A; Duvillard P; Godefroy N; Pinel MC
Bull Cancer; 1993 Feb; 80(2):135-41. PubMed ID: 8173164
[TBL] [Abstract][Full Text] [Related]
8. Grading ovarian tumors. Evaluation of decision making by different pathologists.
Baak JP; Delemarre JF; Langley FA; Talerman A
Anal Quant Cytol Histol; 1986 Dec; 8(4):349-53. PubMed ID: 3814302
[TBL] [Abstract][Full Text] [Related]
9. Interpathologist and intrapathologist disagreement in ovarian tumor grading and typing.
Baak JP; Langley FA; Talerman A; Delemarre JF
Anal Quant Cytol Histol; 1986 Dec; 8(4):354-7. PubMed ID: 3814303
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of ovarian carcinoma cell type is highly reproducible: a transcanadian study.
Köbel M; Kalloger SE; Baker PM; Ewanowich CA; Arseneau J; Zherebitskiy V; Abdulkarim S; Leung S; Duggan MA; Fontaine D; Parker R; Huntsman DG; Gilks CB
Am J Surg Pathol; 2010 Jul; 34(7):984-93. PubMed ID: 20505499
[TBL] [Abstract][Full Text] [Related]
11. Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma.
Malpica A; Deavers MT; Tornos C; Kurman RJ; Soslow R; Seidman JD; Munsell MF; Gaertner E; Frishberg D; Silva EG
Am J Surg Pathol; 2007 Aug; 31(8):1168-74. PubMed ID: 17667538
[TBL] [Abstract][Full Text] [Related]
12. Ovarian carcinoma pathology and genetics: recent advances.
Gilks CB; Prat J
Hum Pathol; 2009 Sep; 40(9):1213-23. PubMed ID: 19552940
[TBL] [Abstract][Full Text] [Related]
13. Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria.
Hauptmann S; Friedrich K; Redline R; Avril S
Virchows Arch; 2017 Feb; 470(2):125-142. PubMed ID: 28025670
[TBL] [Abstract][Full Text] [Related]
14. Pathology of borderline and invasive cancers.
Prat J
Best Pract Res Clin Obstet Gynaecol; 2017 May; 41():15-30. PubMed ID: 28277307
[TBL] [Abstract][Full Text] [Related]
15. Metastatic ovarian carcinoma to the brain: an approach to identification and classification for neuropathologists.
Nafisi H; Cesari M; Karamchandani J; Balasubramaniam G; Keith JL
Neuropathology; 2015 Apr; 35(2):122-9. PubMed ID: 25377896
[TBL] [Abstract][Full Text] [Related]
16. Ovarian carcinoma histotype determination is highly reproducible, and is improved through the use of immunohistochemistry.
Köbel M; Bak J; Bertelsen BI; Carpen O; Grove A; Hansen ES; Levin Jakobsen AM; Lidang M; Måsbäck A; Tolf A; Gilks CB; Carlson JW
Histopathology; 2014 Jun; 64(7):1004-13. PubMed ID: 24329781
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the reproducibility of the World Health Organization classification of common ovarian cancers. With emphasis on methodology.
Cramer SF; Roth LM; Ulbright TM; Mazur MT; Nunez CA; Gersell DJ; Mills SE; Kraus FT
Arch Pathol Lab Med; 1987 Sep; 111(9):819-29. PubMed ID: 3632299
[TBL] [Abstract][Full Text] [Related]
18. External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma.
Lee JY; Chung YS; Na K; Kim HM; Park CK; Nam EJ; Kim S; Kim SW; Kim YT; Kim HS
J Gynecol Oncol; 2017 Nov; 28(6):e73. PubMed ID: 28758379
[TBL] [Abstract][Full Text] [Related]
19. The pathological assessment of ovarian neoplasms. III: The malignant "epithelial" tumours.
Russell P
Pathology; 1979 Jul; 11(3):493-532. PubMed ID: 230444
[TBL] [Abstract][Full Text] [Related]
20. [Ovarian epithelial tumors of borderline malignancy].
Katoh K; Izumi R
Rinsho Byori; 1992 Feb; 40(2):119-31. PubMed ID: 1583784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
